期刊文献+

重症感染非抗感染措施的思考 被引量:1

Consideration of Contemporary non-anti-infective Therapies of Severe Sepsis
下载PDF
导出
摘要 近年来严重感染与感染性休克治疗策略的主要进展是对强化血糖控制、糖皮质激素等疗法的再评价。同时,也出现了诸如血管加压素、他汀类药物、选择性口腔/肠道脱污染等新的治疗措施,并取得了一定成果。本文对相关研究进展进行综述,以阐明集束化策略和管理水平的提高可能是最终降低重症感染病死率的关键。 Contemporary achievements in management of severe sepsis and septic shock were mainly focus on the reevaluation of intensive glucose controlling and corticosteroid therapies. Meanwhile, new strategies, including vasopressin, statins, selective decontamination of digestive tract and oropharynx also presented confidential results. The present paper aims to draw a systemic review on these advancements and to highlight the consideration that both bundle strategies and high--level management play vital roles in decreasing mortality of critically ill patients.
作者 黄伟 万献尧
出处 《医学与哲学(B)》 2010年第5期51-52,63,共3页 Medicine & Philosophy(B)
关键词 严重感染 感染性休克 治疗 集束化 severe sepsis, septic shock, management, bundle
  • 相关文献

参考文献20

  • 1Dellinger R P, Carlet J M, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock [J]. Crit Care Med, 2001, 32(3):858-873.
  • 2Dellinger R P, Levy M M, Carlet J M, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock[J]. Intensive Care Med, 2008, 34(1):17-60.
  • 3Annane D, Sebille V. Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septicshock[J]. JAMA, 2002, 288(7):862-871.
  • 4Sprung C L, Annane D, Keh D. et al. Hydrocortisone Therapy for Patients with Septic Shock[J]. N Engl J Med, 2008, 358(2)1111-124.
  • 5Minneci P C, Deans K J, Eichacker P Q, et al. The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-a nalysis[J]. Clin Microbiol Infect, 2009,15,308(4):308-318.
  • 6Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients[J].N Engl J Med, 2001, 345 (19):1359-1367.
  • 7Wiener R S, Wiener D C, l.arson R J. Benefits and risks of tight glucose control in critically ill adults:a meta-analysis[JJ. JAMA, 2008,300(8):933-944.
  • 8The NICE SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients[J].N Engl J Med, 2009, 360 ( 13) : 1283-1297.
  • 9Preiser J C, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study[J]. Intensive Care Med, 2009. 35(10):1738-1748.
  • 10Russell J A, Walley K R, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock[J].N Engl J Med, 2008, 3,58(9):877-887.

二级参考文献33

  • 1黄伟,万献尧.急性肺损伤/急性呼吸窘迫综合征小潮气量通气策略的争议[J].中国呼吸与危重监护杂志,2003,2(6):377-378. 被引量:5
  • 2刘大为.严重感染和感染性休克的集束治疗策略[J].中华外科杂志,2006,44(17):1178-1180. 被引量:36
  • 3Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med ,2004,32:858-873.
  • 4Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign:international guidelines for management of severe sepsis and septic shock. Intensive Care Med,2008,34:17-60.
  • 5Townsend SR, Schorr C, Levy MM, et al. Reducing Mortality in Severe Sepsis: The Surviving Sepsis Campaign. Clin Chest Med, 2008,29 : 721-733.
  • 6Remiek DG. Pathophysiology of sepsis. Am J Pathol, 2007, 170: 1435-1444.
  • 7van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med ,2001,345:1359- 1367.
  • 8van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med,2006,354:449-461.
  • 9Krinsley J. Glycemic Control in critically ill patients: Leuven and Beyond. Chest ,2007,132 : 1-2.
  • 10Rivers E, Nguyen B, Havstad S. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med,2001, 345 : 1368-1377.

共引文献23

同被引文献18

  • 1成人严重感染与感染性休克血流动力学监测与支持指南[J].中华医学信息导报,2007,22(16):21-22. 被引量:9
  • 2Dahl K N,Kalinowski A,Pekkan K. Mechanobiology and the mi crocirculation: cellular,nuclear and fluid mechanics [J]. Microcircu- lation,2010,17 (3) :179- 191.
  • 3De Backer D, Hollenberg S, Boerma C, et al. How to evaluate the microcirculation: report of a round table conference[J]. Crit Care, 2007, 11(5) ;R101.
  • 4Wong C K,Lain C W,Wu A K,et al. Plasma inflammatory eyto- kines and chemokines in severe acute respiratory syndrome[J]. Clin Exp Immunol, 2004, 136(1) :95-103.
  • 5Secor D, Li F, Ellis C G,et al. Impaired microvaseular perfusion in sepsis requires activated coagulation and P -- seteetin-- mediated platelet adhesion in capillaries[J]. Intensive Care Med, 2010, 36 (11) :1928-1934.
  • 6Verdant C L, De Backer D,Bruhn A, et al. Evaluation of sublin gual and gut mucosal microcirculation in sepsis= a quantitative anal- ysis[J].Crit Care Med,2009, 37(11) :2875-2881.
  • 7Taccone F S, Su F, Pierrakos C, et al. Cerebral microcirculation is impaired during sepsis: anexperimental study[J].Crit Care, 2010, 14(4) :R140.
  • 8Huet O, Dupic L, Harrois A, et al. Oxidative stress and endothe lial dysfunction during sepsis [J]. Front Biosci, 2011,16 :1986 - 1995.
  • 9Ait--Oufella H, Maury E, Lehoux S, et al. The endothelium: physiological functions and role in microcirculatory failure during severe sepsis[J]. Intensive Care Med,2010,36(8):1286-1298.
  • 10Ferrari M, Jung C, Lauten A, et al. Evaluation of microcirculato- ry disorders in shock patients[J]. Dtsch Med Wochenschr, 2011, 136(19) :1009-1013.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部